Hepatitis B virus articles within Scientific Reports

Featured

• Article
  21 August 2023 | Open Access

  TRIM26 positively affects hepatitis B virus replication by inhibiting proteasome-dependent degradation of viral core protein

  • Yuki Nakaya
  • , Tsutomu Nishizawa
  •  & Kazumoto Murata

• Article
  09 May 2023 | Open Access

  HCV, HIV AND HBV rapid test diagnosis in non-clinical outreach settings can be as accurate as conventional laboratory tests

  • Milagros Muñoz-Chimeno
  • , Jorge Valencia
  •  & Pablo Ryan

• Article
  15 April 2023 | Open Access

  The specific core fucose-binding lectin Pholiota squarrosa lectin (PhoSL) inhibits hepatitis B virus infection in vitro

  • Tsunenori Ouchida
  • , Haruka Maeda
  •  & Eiji Miyoshi

• Article
  23 November 2022 | Open Access

  Hepatitis A and hepatitis B infection risk among employees at schools for disabled pupils

  • Felix Lang
  • , Klaus Schoene
  •  & Peter Kegel

• Article
  17 June 2022 | Open Access

  Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants

  • Caroline Lefeuvre
  • , Marine Roux
  •  & Alexandra Ducancelle

• Article
  14 March 2022 | Open Access

  Natural antibody IgG levels are associated with HBeAg-positivity and seroconversion in chronic hepatitis B patients treated with entecavir

  • Youkyung H. Choi
  • , Hyun Woong Lee
  •  & Michael A. Purdy

• Article
  21 February 2022 | Open Access

  A novel hepadnavirus in domestic dogs

  • Georgia Diakoudi
  • , Paolo Capozza
  •  & Vito Martella

• Article
  27 September 2021 | Open Access

  Curcumin inhibited hepatitis B viral entry through NTCP binding

  • Piyanoot Thongsri
  • , Yongyut Pewkliang
  •  & Khanit Sa-ngiamsuntorn

• Article
  07 July 2021 | Open Access

  Clinical, epidemiological aspects, and trends of Hepatitis B in Brazil from 2007 to 2018

  • Cathianne Sacramento Pinto
  • , Galileu Barbosa Costa
  •  & Sandra Rocha Gadelha

• Article
  03 June 2021 | Open Access

  A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus

  • S. Kiruthika
  • , Ruchika Bhat
  •  & B. Jayaram

• Article
  21 April 2021 | Open Access

  Hepatitis B virus infection among pregnant mothers and children after the introduction of the universal vaccination program in Central Vietnam

  • Masami Miyakawa
  • , Lay-Myint Yoshida
  •  & Hiroyuki Moriuchi

• Article
  10 December 2020 | Open Access

  Establishment of a novel hepatitis B virus culture system using immortalized human hepatocytes

  • Yuichi Akahori
  • , Hiroki Kato
  •  & Makoto Hijikata

• Article
  03 December 2020 | Open Access

  Quantification and epigenetic evaluation of the residual pool of hepatitis B covalently closed circular DNA in long-term nucleoside analogue-treated patients

  • Fanny Lebossé
  • , Aurore Inchauspé
  •  & Fabien Zoulim

• Article
  23 September 2020 | Open Access

  The fatty-acid amide hydrolase inhibitor URB597 inhibits MICA/B shedding

  • Kazuma Sekiba
  • , Motoyuki Otsuka
  •  & Kazuhiko Koike

• Article
  24 August 2020 | Open Access

  Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models

  • Peter Jianrui Liu
  • , James M. Harris
  •  & Jane A. McKeating

• Article
  20 February 2020 | Open Access

  Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudine

  • Yoshiaki Yasutake
  • , Shin-ichiro Hattori
  •  & Hiroaki Mitsuya

• Article
  22 January 2020 | Open Access

  Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway

  • Kazuhiro Murai
  • , Hayato Hikita
  •  & Tetsuo Takehara

• Article
  21 January 2020 | Open Access

  HBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA

  • Chun Kong Chong
  • , Ching Yan Serene Cheng
  •  & Danny Ka-Ho Wong

• Article
  08 January 2020 | Open Access

  Development of a novel anti-hepatitis B virus agent via Sp1

  • Michiyo Hayakawa
  • , Hideaki Umeyama
  •  & Yoshiki Murakami

• Article
  30 December 2019 | Open Access

  Characterization and engineering of broadly reactive monoclonal antibody against hepatitis B virus X protein that blocks its interaction with DDB1

  • Shuai Tao
  • , Shaokun Pan
  •  & Jing Liu

• Article
  07 November 2019 | Open Access

  Direct interaction between the hepatitis B virus core and envelope proteins analyzed in a cellular context

  • Florentin Pastor
  • , Charline Herrscher
  •  & Christophe Hourioux

• Article
  23 July 2019 | Open Access

  Identification of hepadnavirus in the sera of cats

  • Gianvito Lanave
  • , Paolo Capozza
  •  & Michele Camero

• Article
  19 July 2019 | Open Access

  Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients

  • Ondrej Podlaha
  • , Edward Gane
  •  & Kosh Agarwal

• Article
  10 July 2019 | Open Access

  Generation and characterization of a stable cell line persistently replicating and secreting the human hepatitis delta virus

  • Yi Ni
  • , Zhenfeng Zhang
  •  & Stephan Urban

• Article
  11 June 2019 | Open Access

  Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBP

  • Grace Naswa Makokha
  • , Hiromi Abe-Chayama
  •  & Kazuaki Chayama

• Article
  08 May 2019 | Open Access

  Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)

  • Anna L. McNaughton
  • , Hannah E. Roberts
  •  & Philippa C. Matthews

• Article
  12 February 2019 | Open Access

  Suppressing the NHEJ pathway by DNA-PKcs inhibitor NU7026 prevents degradation of HBV cccDNA cleaved by CRISPR/Cas9

  • Dmitry Kostyushev
  • , Anastasiya Kostyusheva
  •  & Vladimir Chulanov

• Article
  07 February 2019 | Open Access

  Notch signaling facilitates hepatitis B virus covalently closed circular DNA transcription via cAMP response element-binding protein with E3 ubiquitin ligase-modulation

  • Zijing Wang
  • , Kazunori Kawaguchi
  •  & Shuichi Kaneko

• Article
  24 December 2018 | Open Access

  Expansion of viral variants associated with immune escape and impaired virion secretion in patients with HBV reactivation after resolved infection

  • Tadashi Inuzuka
  • , Yoshihide Ueda
  •  & Hiroyuki Marusawa

• Article
  19 October 2018 | Open Access

  Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads

  • Yayun Lin
  • , Yan Liu
  •  & Guiqin Bai

• Article
  04 October 2018 | Open Access

  A Next-Generation Sequencing-Based Platform for Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma of Hepatocellular Carcinoma Patients

  • Chiao-Fang Teng
  • , Hsi-Yuan Huang
  •  & Long-Bin Jeng

• Article
  13 August 2018 | Open Access

  Early-onset liver cancer in South America associates with low hepatitis B virus DNA burden

  • Agnès Marchio
  • , Juan Pablo Cerapio
  •  & Pascal Pineau

• Article
  23 May 2018 | Open Access

  HDV infection rates in northern Vietnam

  • Mai Thanh Binh
  • , Nghiem Xuan Hoan
  •  & Thirumalaisamy P. Velavan

• Article
  23 May 2018 | Open Access

  Distinctiveness in virological features and pathogenic potentials of subgenotypes D1, D2, D3 and D5 of Hepatitis B virus

  • Mousumi Khatun
  • , Rajiv Kumar Mondal
  •  & Simanti Datta

• Article
  29 March 2018 | Open Access

  Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes

  • Julie Lucifora
  • , Marc Bonnin
  •  & David Durantel

• Article
  22 February 2018 | Open Access

  Cisplatin Enhances Hepatitis B Virus Replication and PGC-1α Expression through Endoplasmic Reticulum Stress

  • Xiaosong Li
  • , E. Pan
  •  & Ailong Huang

• Article
  30 November 2017 | Open Access

  A robust cell culture system supporting the complete life cycle of hepatitis B virus

  • Eleftherios Michailidis
  • , Jonathan Pabon
  •  & Charles M. Rice

• Article
  10 November 2017 | Open Access

  Memory Regulatory T cells Increase Only In Inflammatory Phase of Chronic Hepatitis B Infection and Related to Galectin-9/Tim-3 interaction

  • Ching-Chih Hu
  • , Wen-Juei Jeng
  •  & Chun-Yen Lin

• Article
  31 October 2017 | Open Access

  Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus

  • Gansukh Choijilsuren
  • , Ren-Shiang Jhou
  •  & Chiaho Shih

• Article
  30 October 2017 | Open Access

  HBeAg-induced miR-106b promotes cell growth by targeting the retinoblastoma gene

  • Jasmine Samal
  • , Manish Kandpal
  •  & Perumal Vivekanandan

• Article
  05 October 2017 | Open Access

  IFN-α-mediated Base Excision Repair Pathway Correlates with Antiviral Response Against Hepatitis B Virus Infection

  • Yong Li
  • , Yuchen Xia
  •  & Qin Ning

• Article
  29 August 2017 | Open Access

  Synergistic impact of mutations in Hepatitis B Virus genome contribute to its occult phenotype in chronic Hepatitis C Virus carriers

  • Rajiv Kumar Mondal
  • , Mousumi Khatun
  •  & Simanti Datta

• Article
  29 August 2017 | Open Access

  Cell-permeable capsids as universal antigen carrier for the induction of an antigen-specific CD8⁺ T-cell response

  • Sami Akhras
  • , Masako Toda
  •  & Eberhard Hildt

• Article
  02 August 2017 | Open Access

  Few basepairing-independent motifs in the apical half of the avian HBV ε RNA stem-loop determine site-specific initiation of protein-priming

  • Markus Gajer
  • , Katharina Dörnbrack
  •  & Michael Nassal

• Article
  27 July 2017 | Open Access

  Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance (2005–2013) in eastern China

  • Bingyu Yan
  • , Jingjing Lv
  •  & Li Zhang

• Article
  21 July 2017 | Open Access

  Suppression of HBV replication by the expression of nickase- and nuclease dead-Cas9

  • Takeshi Kurihara
  • , Takasuke Fukuhara
  •  & Yoshiharu Matsuura

• Article
  01 June 2017 | Open Access

  Transgenic hepatitis B: a new model of HBV infection

  • Hubert D.-J. Daniel
  •  & Michael Torbenson

• Article
  12 May 2017 | Open Access

  Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL

  • Chih-Chien Yao
  • , Chao-Hung Hung
  •  & Chien-Hung Chen

• Article
  13 February 2017 | Open Access

  Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms

  • Zheng Zhou
  • , Taishan Hu
  •  & Ning Qin

• Article
  03 February 2017 | Open Access

  Efficient genome replication of hepatitis B virus using adenovirus vector: a compact pregenomic RNA-expression unit

  • Mariko Suzuki
  • , Saki Kondo
  •  & Yumi Kanegae